In gratitude of the loyal support of our members, the CNS is offering complimentary 2021 Annual Meeting registration to all members! Learn more.

  • Safety and Efficacy of Flow Diversion for Middle Cerebral Artery Aneurysms

    Final Number:
    1031

    Authors:
    Chau D. Vo BA; Jessica K. Campos MD; Matthew T Bender MD; Bowen Jiang MD; David A. Zarrin BS; Arun Chandra BS; Justin M. Caplan MD; Judy Huang MD; Rafael J Tamargo; Li-Mei Lin MD; Geoffrey P. Colby MD, PhD; Alexander L. Coon MD

    Study Design:
    Clinical Trial

    Subject Category:

    Meeting: Congress of Neurological Surgeons 2018 Annual Meeting

    Introduction: The Pipeline Embolization Device has demonstrated safety and efficacy in a variety of off-label applications, with limited reports of its use for aneurysms along the middle cerebral artery.

    Methods: Patients with MCA aneurysms treated with flow diversion were identified. Follow-up angiography was performed at 6 and 12 months. Occlusion was graded as complete, trace filling, entry remnant, or aneurysm filling. Clopidogrel was discontinued at 6 months; aspirin was reduced to 81mg from 325mg daily at 12 months.

    Results: There were 40 cases of flow diversion for 41 MCA aneurysms, with 93%(38/40) successful rate. Twenty-nine patients(76%) were female. Average age was 53±15years, average size 5.4±4.7mm, neck size 2.7±1.1mm. Ten aneurysms arose from M1(26%), 22 MCA bifurcation(58%), 5 M2(13%) and 1 distal MCA(3%). Average size of MCA bifurcation aneurysms was 5.2mm(1.8-15mm), neck size 3mm(1.5-5.5mm). Thirteen cases(34%) had previous treatment, and 14(37%) had subarachnoid hemorrhage. Morphology was 89%saccular, 8%fusiform and 1%dissecting. Balloon remodeling was performed in 2 cases(5%), adjunctive coiling in 4 cases(11%). There were 2 in-situ thromboses(5%). One occurrence resolved following abciximab administration with no clinical significance. The other, an irregular right MCA bifurcation aneurysm treated with PED and coiling, was complicated by intra-procedural in-stent platelet accumulation and resolved with abciximab administration, however, the patient suffered left lower extremity paresis with mRS4 at last follow-up. This was the only major complication(1/38;2.6%), and no mortalities. Minor complications(3/38;8%) included one minor stroke, one asymptomatic ICA dissection, and one post-operative cranial nerve III palsy without evidence for carotid cavernous fistula. Follow-up angiography was available for 34/38(89%) cases at average 12.4 months. Complete occlusion was achieved in 66%(n=25), and 74%(n=28), at 6-, and 12-months, respectively. Of 14/19 MCA bifurcation aneurysms with available follow-up, 74% were completely occluded at average 11 months.

    Conclusions: Treatment of MCA aneurysms with PED offers a favorable occlusion rate(74%) with acceptable major complication rate(2.6%).

    Patient Care: Improved understanding of the safety and efficacy of flow diversion embolization using the Pipeline embolization device when treating cerebral aneurysms along the middle cerebral artery.

    Learning Objectives: By the conclusion of this session, participants should be able to: 1) Describe the safety and efficacy of flow diversion embolization in treating MCA aneurysms

    References:

We use cookies to improve the performance of our site, to analyze the traffic to our site, and to personalize your experience of the site. You can control cookies through your browser settings. Please find more information on the cookies used on our site. Privacy Policy